407 related articles for article (PubMed ID: 19587496)
1. Risk factors of post renal transplant hyperparathyroidism.
Hamidian Jahromi A; Roozbeh J; Raiss-Jalali GA; Dabaghmanesh A; Jalaeian H; Bahador A; Nikeghbalian S; Salehipour M; Salahi H; Malek-Hosseini A
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):573-6. PubMed ID: 19587496
[TBL] [Abstract][Full Text] [Related]
2. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
[TBL] [Abstract][Full Text] [Related]
3. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study.
Evenepoel P; Claes K; Kuypers D; Maes B; Bammens B; Vanrenterghem Y
Nephrol Dial Transplant; 2004 May; 19(5):1281-7. PubMed ID: 14993493
[TBL] [Abstract][Full Text] [Related]
4. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.
Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid function after successful renal transplantation.
Botha JF; Botha JR
S Afr J Surg; 1997 Aug; 35(3):113-6. PubMed ID: 9429326
[TBL] [Abstract][Full Text] [Related]
6. Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients.
Ozdemir FN; Afsar B; Akgul A; Usluoğullari C; Akçay A; Haberal M
Transplant Proc; 2006 Mar; 38(2):480-2. PubMed ID: 16549153
[TBL] [Abstract][Full Text] [Related]
7. Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study.
Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Ando K; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
Ther Apher Dial; 2011 Oct; 15(5):481-7. PubMed ID: 21974702
[TBL] [Abstract][Full Text] [Related]
8. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
Chow TL; Chan TT; Ho YW; Lam SH
Arch Surg; 2007 Jul; 142(7):644-8. PubMed ID: 17638802
[TBL] [Abstract][Full Text] [Related]
9. Pre-transplant calcium-phosphate-parathormone homeostasis as a risk factor for early graft dysfunction.
Ahmadi F; Ali-Madadi A; Lessan-Pezeshki M; Khatami M; Mahdavi-Mazdeh M; Razeghi E; Maziar S; Seifi S; Abbasi M
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):54-8. PubMed ID: 18087123
[TBL] [Abstract][Full Text] [Related]
10. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
[TBL] [Abstract][Full Text] [Related]
11. Predictors of hyperparathyroidism in renal transplant recipients.
Houssaini TS; Arrayhani M; Rhou H; Amar Y; Benamar L; Ouzeddoun N; Bayahia R
Saudi J Kidney Dis Transpl; 2008 May; 19(3):401-3. PubMed ID: 18445900
[TBL] [Abstract][Full Text] [Related]
12. Serum parathyroid hormone levels following renal transplantation: post-transplant hypercalcemia.
Pierides AM; Thein-Than ; Cook DB
Clin Nephrol; 1974; 2(4):136-42. PubMed ID: 4603151
[No Abstract] [Full Text] [Related]
13. Bone metabolism according to chronic kidney disease stages in patients undergoing kidney transplantation: a 5-year database analysis.
Fernández-Fresnedo G; Rodrigo E; Ruiz JC; Martín de Francisco AL; Arias M
Transplant Proc; 2009; 41(6):2403-5. PubMed ID: 19715933
[TBL] [Abstract][Full Text] [Related]
14. Impact of adequate dialysis before transplantation on development of chronic renal allograft dysfunction in 3-year posttransplant period.
Hamidian Jahromi A; Raiss-Jalali GA; Roozbeh J
Transplant Proc; 2006 Sep; 38(7):2003-5. PubMed ID: 16979979
[TBL] [Abstract][Full Text] [Related]
15. Calcium and phosphorus metabolism in stable renal transplant recipients.
Khosroshahi HT; Shoja MM; Azar SA; Tubbs RS; Safa J; Etemadi J; Ardalan MR
Exp Clin Transplant; 2007 Dec; 5(2):670-2. PubMed ID: 18194119
[TBL] [Abstract][Full Text] [Related]
16. Decreased renal transplant function after parathyroidectomy.
Schwarz A; Rustien G; Merkel S; Radermacher J; Haller H
Nephrol Dial Transplant; 2007 Feb; 22(2):584-91. PubMed ID: 17035377
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for osteoporosis in young renal transplant recipients.
Sezer S; Ozdemir FN; Ibis A; Sayin B; Haberal M
Transplant Proc; 2005 Sep; 37(7):3116-8. PubMed ID: 16213324
[TBL] [Abstract][Full Text] [Related]
18. The effects of mineral metabolism markers on renal transplant outcomes.
Marcén R; Jimenez S; Fernández A; Galeano C; Villafruela JJ; Burgos FJ; Quereda C
Transplant Proc; 2012 Nov; 44(9):2567-9. PubMed ID: 23146456
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice.
Muirhead N; Zaltman JS; Gill JS; Churchill DN; Poulin-Costello M; Mann V; Cole EH
Clin Transplant; 2014 Feb; 28(2):161-5. PubMed ID: 24329899
[TBL] [Abstract][Full Text] [Related]
20. Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation.
Dolgos S; Hartmann A; Bønsnes S; Ueland T; Isaksen GA; Godang K; Pfeffer P; Bollerslev J
Clin Transplant; 2008; 22(4):462-8. PubMed ID: 18318737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
